Global Ticagrelor Market Analysis By Segmentations, Top Key Players, Geographical Expansion, Future Development & Forecast 2024-2035
- PUBLISHED ON
- 1/12/2023
- NO OF PAGES
- 249
- CATEGORY
- Healthcare & Life Sciences
Overview
Ticagrelor is a medication that is used to prevent blood clots in people with acute coronary syndrome, a condition that can lead to heart attacks or strokes. It is sold under the brand name Brilinta and is classified as a platelet aggregation inhibitor.
The ticagrelor market has been steadily growing over the years due to the increasing incidence of acute coronary syndrome and the growing awareness about the benefits of antiplatelet drugs in preventing blood clots. The market growth can be attributed to several factors such as the increasing prevalence of cardiovascular diseases, growing geriatric population, and rising demand for personalized medicine. Additionally, the launch of new formulations, increasing R&D activities, and favourable reimbursement policies are also expected to drive the market growth in the coming years.
North America is currently the largest market for ticagrelor, followed by Europe and Asia-Pacific. The dominance of these regions can be attributed to the high prevalence of cardiovascular diseases, well-established healthcare infrastructure, and increasing awareness about the benefits of antiplatelet drugs.
Some of the key players operating in the ticagrelor market include AstraZeneca, Hunan Warrant Pharmaceutical Co., Ltd., Zydus Cadila, Teva Pharmaceutical Industries Ltd., and Sun Pharmaceutical Industries Ltd., among others. These players are actively involved in R&D activities to develop new formulations and expand their product portfolio to cater to the growing demand for ticagrelor.
Segment Overview
The ticagrelor market can be segmented based on various factors such as application, dosage form, distribution channel, and region.
1. Application: Ticagrelor is primarily used in the prevention of thrombotic events in patients with acute coronary syndrome. It can also be used in patients with a history of heart attack or stroke. Therefore, the market can be segmented based on its application in the treatment of acute coronary syndrome and other cardiovascular diseases.
2. Dosage Form: Ticagrelor is available in oral tablets and injectable formulations. The oral tablets are the most commonly prescribed dosage form. The market can be segmented based on the dosage form, with the oral tablets segment being the largest.
3. Distribution Channel: Ticagrelor is sold through various distribution channels such as hospitals, pharmacies, and online channels. The hospital segment is the largest, as ticagrelor is primarily used in hospitals for the treatment of acute coronary syndrome.
4. Region: The ticagrelor market can be segmented based on the region, with North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa being the major regions. North America is currently the largest market for ticagrelor, followed by Europe and Asia-Pacific.
Overall, the ticagrelor market is expected to witness significant growth in the coming years due to the increasing prevalence of cardiovascular diseases and the growing awareness about the benefits of antiplatelet drugs. The market segmentation will help the manufacturers and marketers to better understand the market trends and develop targeted marketing strategies to reach their customers.
Geographical Overview
The ticagrelor market is a global market, with North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa being the major regions.
1. North America: North America is currently the largest market for ticagrelor. The high prevalence of cardiovascular diseases, well-established healthcare infrastructure, and increasing awareness about the benefits of antiplatelet drugs are some of the factors driving the market growth in this region.
2. Europe: Europe is the second-largest market for ticagrelor. The growing geriatric population and increasing incidence of cardiovascular diseases are some of the factors contributing to the market growth in this region.
3. Asia-Pacific: The Asia-Pacific region is expected to witness significant growth in the ticagrelor market in the coming years. The increasing healthcare expenditure, growing awareness about cardiovascular diseases, and rising demand for personalized medicine are some of the factors driving the market growth in this region.
4. Latin America: The ticagrelor market in Latin America is expected to grow at a significant rate due to the increasing incidence of cardiovascular diseases and growing demand for antiplatelet drugs.
5. Middle East & Africa: The ticagrelor market in the Middle East & Africa region is also expected to witness significant growth in the coming years due to the increasing healthcare expenditure, growing awareness about cardiovascular diseases, and rising demand for antiplatelet drugs.
Overall, the ticagrelor market is expected to witness significant growth across all regions, with North America and Europe being the major markets due to the high prevalence of cardiovascular diseases and well-established healthcare infrastructure. However, the Asia-Pacific region is expected to witness the fastest growth in the coming years due to the increasing healthcare expenditure and rising demand for personalized medicine.
COVID Impact
The COVID-19 pandemic has had a mixed impact on the ticagrelor market. While the pandemic has led to disruptions in the supply chain and reduced patient visits to hospitals and clinics, it has also led to increased awareness about the importance of preventing and managing cardiovascular diseases, which has led to an increased demand for antiplatelet drugs such as ticagrelor.
The pandemic has had a significant impact on the supply chain of ticagrelor, with disruptions in the manufacturing and distribution of the drug. However, the pharmaceutical industry has responded by ramping up production and finding alternative supply sources to ensure the availability of the drug.
The pandemic has also led to a reduction in patient visits to hospitals and clinics for non-COVID related health issues, including cardiovascular diseases. This has led to a reduction in the number of patients being diagnosed with acute coronary syndrome and a reduction in the demand for ticagrelor.
However, the pandemic has also led to an increased awareness about the importance of managing cardiovascular diseases, as patients with pre-existing cardiovascular conditions are at a higher risk of developing severe COVID-19. This has led to an increased demand for antiplatelet drugs such as ticagrelor, as they are an important component of the management of cardiovascular diseases.
Overall, the impact of the COVID-19 pandemic on the ticagrelor market has been mixed, with disruptions in the supply chain and reduced patient visits to hospitals and clinics leading to a reduction in demand, but increased awareness about the importance of managing cardiovascular diseases leading to an increased demand for antiplatelet drugs such as ticagrelor.
Competitive Analysis
The ticagrelor market is highly competitive, with several major players operating in the market. Some of the key players in the market include:
1. AstraZeneca: AstraZeneca is the manufacturer of Brilinta, the brand name for ticagrelor. It is one of the leading players in the market, with a strong presence in North America, Europe, and Asia-Pacific.
2. Pfizer Inc.: Pfizer is another major player in the ticagrelor market, with its antiplatelet drug, Effient (prasugrel), which is used in the treatment of acute coronary syndrome.
3. Sanofi S.A.: Sanofi is a leading player in the antiplatelet market, with its drug Plavix (clopidogrel) being one of the most widely used antiplatelet drugs in the world. Sanofi also manufactures Ticlopidine, which is another antiplatelet drug used in the treatment of cardiovascular diseases.
4. Johnson & Johnson: Johnson & Johnson is another major player in the ticagrelor market, with its antiplatelet drug, Xarelto (rivaroxaban), which is used in the treatment of deep vein thrombosis and pulmonary embolism.
5. Eli Lilly and Company: Eli Lilly is a major player in the cardiovascular drug market, with its drug Effient (prasugrel), which is used in the treatment of acute coronary syndrome.
Other players in the market include Bristol-Myers Squibb, Daiichi Sankyo, and Boehringer Ingelheim. The key strategies adopted by these players in the market include new product launches, partnerships, mergers and acquisitions, and geographic expansion.
Key Benefits:
• The analysis provides an overview of the factors driving and limiting the growth of the market including trends, structure and others.
• Market estimation for type and geographic segments is derived from the current market scenario and expected market trends.
• Porter’s Five Force Model and SWOT analysis are used to study the global Ticagrelor market and would help stakeholders make strategic decisions.
• The analysis assists in understanding the strategies adopted by the companies for the growth of this market.
• In-depth analysis of the types of Ticagrelor would help in identifying future applications in this market.
Reasons to Purchase this Report:
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Objectives of the Study:
• To provide with an exhaustive analysis on the Ticagrelor Market by Product, By Application, By End User and by Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
Historic Year: 2016-2022
Forecast: 2024-2035
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Ticagrelor Revenue
1.4 Market Analysis by Type
1.4.1 Global Ticagrelor Market Size Growth Rate by Type: 2023 VS 2032
1.4.2 90 mg Tablet
1.4.3 60 mg Tablet
1.5 Market by Application
1.5.1 Global Ticagrelor Market Share by Application: 2023-2032
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Ticagrelor Market
1.8.1 Global Ticagrelor Market Status and Outlook (2017-2032)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Ticagrelor Production Capacity Market Share by Manufacturers (2017-2022)
2.2 Global Ticagrelor Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Ticagrelor Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Ticagrelor Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Ticagrelor Sales Volume Market Share by Region (2017-2022)
3.2 Global Ticagrelor Sales Revenue Market Share by Region (2017-2022)
3.3 North America Ticagrelor Sales Volume
3.3.1 North America Ticagrelor Sales Volume Growth Rate (2017-2022)
3.3.2 North America Ticagrelor Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.4 East Asia Ticagrelor Sales Volume
3.4.1 East Asia Ticagrelor Sales Volume Growth Rate (2017-2022)
3.4.2 East Asia Ticagrelor Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.5 Europe Ticagrelor Sales Volume (2017-2022)
3.5.1 Europe Ticagrelor Sales Volume Growth Rate (2017-2022)
3.5.2 Europe Ticagrelor Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.6 South Asia Ticagrelor Sales Volume (2017-2022)
3.6.1 South Asia Ticagrelor Sales Volume Growth Rate (2017-2022)
3.6.2 South Asia Ticagrelor Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.7 Southeast Asia Ticagrelor Sales Volume (2017-2022)
3.7.1 Southeast Asia Ticagrelor Sales Volume Growth Rate (2017-2022)
3.7.2 Southeast Asia Ticagrelor Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.8 Middle East Ticagrelor Sales Volume (2017-2022)
3.8.1 Middle East Ticagrelor Sales Volume Growth Rate (2017-2022)
3.8.2 Middle East Ticagrelor Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.9 Africa Ticagrelor Sales Volume (2017-2022)
3.9.1 Africa Ticagrelor Sales Volume Growth Rate (2017-2022)
3.9.2 Africa Ticagrelor Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.10 Oceania Ticagrelor Sales Volume (2017-2022)
3.10.1 Oceania Ticagrelor Sales Volume Growth Rate (2017-2022)
3.10.2 Oceania Ticagrelor Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.11 South America Ticagrelor Sales Volume (2017-2022)
3.11.1 South America Ticagrelor Sales Volume Growth Rate (2017-2022)
3.11.2 South America Ticagrelor Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.12 Rest of the World Ticagrelor Sales Volume (2017-2022)
3.12.1 Rest of the World Ticagrelor Sales Volume Growth Rate (2017-2022)
3.12.2 Rest of the World Ticagrelor Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
4 North America
4.1 North America Ticagrelor Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Ticagrelor Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Ticagrelor Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Ticagrelor Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Ticagrelor Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Ticagrelor Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Ticagrelor Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Ticagrelor Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Ticagrelor Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Ticagrelor Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Ticagrelor Sales Volume Market Share by Type (2017-2022)
14.2 Global Ticagrelor Sales Revenue Market Share by Type (2017-2022)
14.3 Global Ticagrelor Sales Price by Type (2017-2022)
15 Consumption Analysis by Application
15.1 Global Ticagrelor Consumption Volume by Application (2017-2022)
15.2 Global Ticagrelor Consumption Value by Application (2017-2022)
16 Company Profiles and Key Figures in Ticagrelor Business
16.1 Astrazeneca
16.1.1 Astrazeneca Company Profile
16.1.2 Astrazeneca Ticagrelor Product Specification
16.1.3 Astrazeneca Ticagrelor Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.2 Pfizer
16.2.1 Pfizer Company Profile
16.2.2 Pfizer Ticagrelor Product Specification
16.2.3 Pfizer Ticagrelor Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.3 Bayer
16.3.1 Bayer Company Profile
16.3.2 Bayer Ticagrelor Product Specification
16.3.3 Bayer Ticagrelor Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.4 Johnson & Johnson
16.4.1 Johnson & Johnson Company Profile
16.4.2 Johnson & Johnson Ticagrelor Product Specification
16.4.3 Johnson & Johnson Ticagrelor Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.5 Merck
16.5.1 Merck Company Profile
16.5.2 Merck Ticagrelor Product Specification
16.5.3 Merck Ticagrelor Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.6 Boehringer Ingelheim
16.6.1 Boehringer Ingelheim Company Profile
16.6.2 Boehringer Ingelheim Ticagrelor Product Specification
16.6.3 Boehringer Ingelheim Ticagrelor Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.7 Eli Lilly
16.7.1 Eli Lilly Company Profile
16.7.2 Eli Lilly Ticagrelor Product Specification
16.7.3 Eli Lilly Ticagrelor Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.8 Sun Pharmaceutical
16.8.1 Sun Pharmaceutical Company Profile
16.8.2 Sun Pharmaceutical Ticagrelor Product Specification
16.8.3 Sun Pharmaceutical Ticagrelor Production Capacity, Revenue, Price and Gross Margin (2017-2022)
17 Ticagrelor Manufacturing Cost Analysis
17.1 Ticagrelor Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Ticagrelor
17.4 Ticagrelor Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Ticagrelor Distributors List
18.3 Ticagrelor Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Ticagrelor (2023-2032)
20.2 Global Forecasted Revenue of Ticagrelor (2023-2032)
20.3 Global Forecasted Price of Ticagrelor (2017-2032)
20.4 Global Forecasted Production of Ticagrelor by Region (2023-2032)
20.4.1 North America Ticagrelor Production, Revenue Forecast (2023-2032)
20.4.2 East Asia Ticagrelor Production, Revenue Forecast (2023-2032)
20.4.3 Europe Ticagrelor Production, Revenue Forecast (2023-2032)
20.4.4 South Asia Ticagrelor Production, Revenue Forecast (2023-2032)
20.4.5 Southeast Asia Ticagrelor Production, Revenue Forecast (2023-2032)
20.4.6 Middle East Ticagrelor Production, Revenue Forecast (2023-2032)
20.4.7 Africa Ticagrelor Production, Revenue Forecast (2023-2032)
20.4.8 Oceania Ticagrelor Production, Revenue Forecast (2023-2032)
20.4.9 South America Ticagrelor Production, Revenue Forecast (2023-2032)
20.4.10 Rest of the World Ticagrelor Production, Revenue Forecast (2023-2032)
20.5 Forecast by Type and by Application (2023-2032)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2023-2032)
20.5.2 Global Forecasted Consumption of Ticagrelor by Application (2023-2032)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Ticagrelor by Country
21.2 East Asia Market Forecasted Consumption of Ticagrelor by Country
21.3 Europe Market Forecasted Consumption of Ticagrelor by Countriy
21.4 South Asia Forecasted Consumption of Ticagrelor by Country
21.5 Southeast Asia Forecasted Consumption of Ticagrelor by Country
21.6 Middle East Forecasted Consumption of Ticagrelor by Country
21.7 Africa Forecasted Consumption of Ticagrelor by Country
21.8 Oceania Forecasted Consumption of Ticagrelor by Country
21.9 South America Forecasted Consumption of Ticagrelor by Country
21.10 Rest of the world Forecasted Consumption of Ticagrelor by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached Straits Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2028.
}})
Select a license type that suits your business needs
US $3950
Only Three Thousand Nine Hundred Fifty US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
US $4950
Only Four Thousand Nine Hundred Fifty US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
US $5950
Only Five Thousand Nine Hundred Fifty US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI